Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Satoshi Serada"'
Autor:
Shun Uchida, Satoshi Serada, Yuji Suzuki, Eiji Funajima, Kei Kitakami, Kazumasa Dobashi, Satomi Tamatani, Yuichi Sato, Takaaki Beppu, Kuniaki Ogasawara, Testuji Naka
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 50, Iss , Pp 100982- (2024)
Glioblastoma is the deadliest form of brain tumor. The presence of the blood–brain barrier (BBB) significantly hinders chemotherapy, necessitating the development of innovative treatment options for this tumor. This report presents the in vitro and
Externí odkaz:
https://doaj.org/article/937a68df2d134b64927973de614e8c9c
Autor:
Yoshikazu Nagase, Kosuke Hiramatsu, Masashi Funauchi, Mayu Shiomi, Tatsuo Masuda, Mamoru Kakuda, Satoshi Nakagawa, Ai Miyoshi, Shinya Matsuzaki, Eiji Kobayashi, Toshihiro Kimura, Satoshi Serada, Yutaka Ueda, Tetsuji Naka, Tadashi Kimura
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Endometrial cancer (EC) is a common gynecologic malignancy and patients with advanced and recurrent EC have a poor prognosis. Although chemotherapy is administered for those patients, the efficacy of current chemotherapy is limite
Externí odkaz:
https://doaj.org/article/2b03d3103a2647edbde2abb81acc9041
Autor:
Mizuki Kanda, Satoshi Serada, Kosuke Hiramatsu, Masashi Funauchi, Kengo Obata, Satoshi Nakagawa, Tomoharu Ohkawara, Okinori Murata, Minoru Fujimoto, Fumiko Chiwaki, Hiroki Sasaki, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 35, Iss , Pp 100853- (2023)
Background: Epithelial ovarian cancer (EOC) is a lethal malignant tumor, for which new treatment options are urgently required. Lipolysis-stimulated lipoprotein receptor (LSR) is widely expressed in EOC, and it is associated with poor prognosis. In t
Externí odkaz:
https://doaj.org/article/8aca4d3343e645dd80e48e4e7a9fbf33
Autor:
Eri Munekage, Satoshi Serada, Shigehiro Tsujii, Keiichiro Yokota, Keita Kiuchi, Kenji Tominaga, Minoru Fujimoto, Mizuki Kanda, Sunao Uemura, Tsutomu Namikawa, Taisei Nomura, Ichiro Murakami, Kazuhiro Hanazaki, Tetsuji Naka
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 9, Pp 939-950 (2021)
An antibody-drug conjugate (ADC) is a promising therapeutic modality because selective and effective delivery of an anti-cancer drug is achieved by drug-conjugated antibody-targeting cancer antigen. Glypican 1 (GPC1) is highly expressed in malignant
Externí odkaz:
https://doaj.org/article/5785173f07364c98b9918dddf1a8cf79
Autor:
Yuka Shibata, Hideki Nakajima, Kimiko Nakajima, Satoshi Serada, Minoru Fujimoto, Tetsuji Naka, Shigetoshi Sano
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 4, Iss 4, Pp 86-88 (2021)
Externí odkaz:
https://doaj.org/article/c090de91f86641428a9bec3566a15ee0
Autor:
Daiki Kato, Tomonori Yaguchi, Takashi Iwata, Yuki Katoh, Kenji Morii, Kinya Tsubota, Yoshiaki Takise, Masaki Tamiya, Haruhiko Kamada, Hiroki Akiba, Kouhei Tsumoto, Satoshi Serada, Tetsuji Naka, Ryohei Nishimura, Takayuki Nakagawa, Yutaka Kawakami
Publikováno v:
eLife, Vol 9 (2020)
Current xenogeneic mouse models cannot evaluate on-target off-tumor adverse effect, hindering the development of chimeric antigen receptor (CAR) T cell therapies for solid tumors, due to limited human/mouse cross-reactivity of antibodies used in CAR
Externí odkaz:
https://doaj.org/article/d030ebf95bdf404e87e0c8329118623a
Autor:
Takaaki Ishida, Takuya Kotani, Satoshi Serada, Minoru Fujimoto, Tohru Takeuchi, Shigeki Makino, Tetsuji Naka
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234090 (2020)
OBJECTIVE:To investigate whether leucine-rich α2-glycoprotein (LRG) can be a biomarker for the disease activity, progression, and prognosis of interstitial pneumonia (IP) in patients with dermatomyositis (DM). METHODS:Correlations between the clinic
Externí odkaz:
https://doaj.org/article/65d5ddad264a4da89be2c491fef8f671
Autor:
Etsuko Kajimoto, Masayuki Endo, Minoru Fujimoto, Shinya Matsuzaki, Makoto Fujii, Kazunobu Yagi, Aiko Kakigano, Kazuya Mimura, Takuji Tomimatsu, Satoshi Serada, Makoto Takeuchi, Kiyoshi Yoshino, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242076 (2020)
This study aimed to determine the association between umbilical cord leucine-rich alpha-2 glycoprotein (LRG) and fetal infection and investigate the underlying mechanism of LRG elevation in fetuses. We retrospectively reviewed the medical records of
Externí odkaz:
https://doaj.org/article/a0a7a56f863f4b2285e7e335b3cbe3a7
Autor:
Hayato Urushima, Minoru Fujimoto, Takashi Mishima, Tomoharu Ohkawara, Hiromi Honda, Hyun Lee, Hirohisa Kawahata, Satoshi Serada, Tetsuji Naka
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-13 (2017)
Abstract Background Leucine-rich alpha 2 glycoprotein (LRG) has been identified as a serum protein elevated in patients with active rheumatoid arthritis (RA). Although the function of LRG is ill-defined, LRG binds with transforming growth factor (TGF
Externí odkaz:
https://doaj.org/article/ce221e8bd3cf4c39a9f317d4d40ccc1d
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153399 (2016)
Amyotrophic Lateral Sclerosis (ALS) is an adult-onset, progressive, motor neuron degenerative disease. Recent evidence indicates that inflammation is associated with many neurodegenerative diseases including ALS. Previously, abnormal levels of inflam
Externí odkaz:
https://doaj.org/article/00adda7bafee4112aa47aef4a19a8c9d